Increased efficacy of influenza virus vaccine candidate through display of recombinant neuraminidase on virus like particles
Vaccination against influenza virus can reduce the risk of influenza by 40% to 60%, they rely on the production of neutralizing antibodies specific to influenza hemagglutinin (HA) ignoring the neuraminidase (NA) as an important surface target. Vaccinat…